Novel combination therapy regimen shows promising results for prostate cancer Isra Zaman22 March 2023 9:00 AM ISTAccording to the National Cancer Institute, prostate cancer is the most common cancer and second leading cause of cancer death among men in the United...
XTANDI plus Leuprolide improves Metastasis-Free survival in men with non-metastatic prostate cancer: Pfizer Ruchika Sharma20 March 2023 11:50 AM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
Conduct Phase III CT : CDSCO panel tells AstraZeneca for anticancer drug Olaparib Film coated Tablet Dr. Divya Colin17 March 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the drug major...
Digital rectal examination of no use for early detection of prostate cancers Dr. Kamal Kant Kohli16 March 2023 9:15 AM ISTThe digital rectal exam (DRE) is widely used by medical professionals to check the prostate gland with a finger for unusual swelling or lumps in the...
Mediterranean diet best prevention against prostate cancer Dr. Kamal Kant Kohli15 March 2023 10:00 AM ISTNew research by University of South Australia scientists has revealed that Mediterranean diet renders the best prevention against prostate cancer....
MRI-guided radiotherapy improves QoL with lesser side effects in patients with localized prostate cancer: JAMA Dr. Kamal Kant Kohli14 March 2023 10:00 AM ISTLos Angeles: A recent study published in JAMA Oncology suggested a significant advantage to MRI-guided radiotherapy that allows aggressive margin...
Medical Bulletin 10/March/2023 Isra Zaman10 March 2023 2:48 PM ISTHere are the top medical news for the day:Natural peptide may tackle the ‘root cause’ of obesity-related conditions, shows studyObesity causes complex...
Study shows advanced imaging may help in clinical treatment of prostate cancer Isra Zaman10 March 2023 9:45 AM ISTA trial conducted at the University Hospital Bonn, in Germany, has been testing the benefit of a scanning method known as PSMA-PET/CT to help target...
Bayer gets EU approval for Nubeqa for additional indication in prostate cancer Ruchika Sharma5 March 2023 1:00 PM ISTNubeqa is developed jointly by Bayer and Orion Corporation, a globally operating Finnish pharmaceutical company.
Janssen seeks USFDA nod for Niraparib and Abiraterone Acetate Dual-Action Tablet, plus Prednisone to treat patients with Metastatic Castration-Resistant Prostate Cancer with BRCA Gene Mutations Ruchika Sharma2 March 2023 3:15 PM ISTMetastatic castration-resistant prostate cancer characterizes cancer that no longer responds to androgen deprivation therapy and has spread to other...
USFDA approves Alembic Pharma anti-cancer injection Docetaxel Ruchika Sharma1 March 2023 3:12 PM ISTDocetaxel Injections are indicated for the breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric adenocarcinoma and...
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 2:15 PM ISTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
